Abstract. Molecular and serologic methods usable for the biological diagnosis of Coltivirus infection are reported. We designed a multiplex reverse transcription-polymerase chain reaction system that allowed the simultaneous and specific amplification of three genomic segments from as little as 0.01 plaque-forming units. Another system in the S2 viral segment permitted the differential diagnosis of American and European viral isolates. We also discuss some improvements of previous ELISAs, and the results obtained with paired sera from Colorado tick fever (CTF) virusinfected individuals. Western blot analysis was developed that allowed the detection of antibodies to a 38-kD viral protein in all tested sera. It also enabled the detection of anti-CTF virus antibodies in ELISA-negative sera. Specific IgM antibodies against a synthetic viral peptide could be detected in sera at the acute stage of the infection. Together, these results should permit the diagnosis of Coltivirus infection at any stage of the pathology.
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Colorado tick fever (CTF) is a severe tick-borne disease that is usually self-limited. This disease occurs in 11 western states in the United States and has also been reported in Canada. 1 Yearly, 200-400 cases are reported throughout the endemic states in the United States. 1, 2 The clinical manifestations appear following the bite of the infected adult Rocky Mountain wood tick Dermacentor andersoni 3 and were first reported in the Rocky Mountain region. 1 It has an abrupt onset with flu-like manifestations and some complications of the disease have been reported, particularly in children. [4] [5] [6] [7] Since the first reports in 1875 to reports of Keiffer and Becker in 1906 and 1926, respectively, 8 on a tick bite-generated biphasic fever having clinical symptoms that does not conform to those of Rocky Mountain spotted fever (RMSF), CTF was recognized as being a separate clinical entity from RMSF. Furthermore, the isolation and characterization of the causative agent, CTF virus, by Florio and others 9 in the 1940s established the viral etiology of the disease. In 1990, the genus Coltivirus was created within the family Reoviridae, encompassing those viruses isolated from vertebrates and invertebrates exhibiting a 12-segment double-stranded (ds) RNA genome. At present, this genus includes the CTF virus, the Eyach virus isolated in Germany in 1976, 10 the two Eyach antigenic variants Ar/T577 and Ar/T578 that were isolated in France in 1981 11 , and other members isolated in Indonesia 12 and China. 13 The Eyach virus has been suspected to be involved in some neurologic manifestations since antibodies to this virus were detected in sera of patients with polyradiculonevritis. 14 The diagnosis of CTF virus infection is made using various procedures. Isolation and characterization by animal inoculation and neutralization were reported to be the most reliable techniques. 8, 15 However, serologic detection by ELI-SA has also been developed. 15 Moreover, many strains were reported 16, 17 that could be detected by RNA-RNA blot hybridization. 18 Recently, we determined the first genomic sequences of the M6, S1, and S2 ds RNA segments of the Florio strain of the CTF virus 19 (GenBank Accession numbers AF000720, U72694, and U53227, respectively). In this paper, we report molecular and serologic procedures for the diagnosis of infection by both American and European isolates of Coltiviruses.
MATERIALS AND METHODS
Virus strains. The Florio strains (N-7180) of CTF virus isolated in 1943 from a patient's serum 9 were obtained from the American Type Culture Collection (ATCC) (Rockville, MD) as lyophilized suckling mouse brain (ATCC refs. VR-90 and VR-1233). The R-1575 and the 69V-28 strains of CTF virus and two related viruses (S6-14-03 and Eyach) were kindly provided by Dr. N. Karabatsos (Centers for Disease Control and Prevention, Fort Collins, CO). The Eyach antigenic variant strain (Ar/T578) was kindly provided by Professor C. Chastel (Virus Laboratory, Faculty of Medicine, University of Brest, Brest, France). Virus was titrated using the plaque assay procedure described previously. 20 Virus growth and purification. Virus was propagated in suspensions of baby hamster kidney (BHK)-21 cells. The virus was purified on a discontinuous sucrose gradient. 21 It was also inoculated by intraperitoneal injections into adult female BALB/c mice. The two CTF strains (R-1575 and 69V-28), the Eyach, the Ar/T578, and the S6-14-03 viruses were replicated by intracerebral injections of suckling mice and recovered seven days postinfection.
Isolation and purification of nucleic acids. The viral ds RNA was extracted from 1) titrated CTF virus combined with human red blood cells, thus mimicking the biological conditions under which the virus is located in infected humans; 6, 22, 23 2) CTF virus-infected mouse blood at the third and fifth days postinfection recovered from the caudal vein; 3) CTF virus-infected BHK-21 cells, and 4) suckling mice brains infected with the R-1575, 69V-28, Ar/T578, Eyach, and S6-14-03 viruses. A guanidinium thiocyanate-derived procedure (RNA NOW; Biogentex, Seabrook, TX) was used in all cases according to the manufacturer's instructions.
Reverse transcription-polymerase chain reaction (RT-PCR) amplification of genomic segments. The extracted viral ds RNA was resuspended in 50 l of diethylpyrocarbonate-treated water. The RNA was denatured by heating 8 l of the RNA solution at 99ЊC for 1 min in the presence of 1.4 l (14.8 %) of dimethylsulfoxide (DMSO).
The reverse transcription was performed at 42ЊC for 1 hr in a final volume of 20 l containing 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT, 0.2 mM of each dNTP, DMSO-denatured ds RNA (the final DMSO con- 
† The underlined part of the primer represents the first 14 bases common to the sense strands of M6, S1, and S2 segments; the remainder of the primer sequence is a tailing to increase the annealing temperature.
‡ The primers were designed from a partial sequence of segment M5.
centration in the reaction mixture was 7%), 0.1 M hexanucleotide mixture, and 10 units of murine myeloid leukemia virus reverse transcriptase (both from Boehringer Mannheim, Mannheim, Germany). Amplification of viral cDNA was performed using segment-specific sets of primers for M5 (M5720PS/ M 5 7 2 0 P A ), M 6 ( M 6 9 8 8 G A / M 6 9 8 8 G B , M 6 T G A S / M6TGAA), S1(S1S302/S1A302 and S1S302/S1A701), and S2 (S2259S/S2259A, COLSENS/COLREV, and S2259S/COLREV) genomic segments of the CTF virus. Primers sequences are shown in Table 1 .
The PCR amplification was done in a volume of 100 l. The reaction mixture included 10 mM Tris-HCl (pH 8.8), 50 mM KCl, 1.5mM MgCl 2 , 0.1% Triton X-100, 0.2 mM of each dNTP, 20 l of the cDNA solution, 1M of each primer, and 2.5 units of Taq DNA polymerase (Boehringer Mannheim). Amplification was carried out using 35 cycles of denaturation at 94ЊC for 50 sec, annealing at 55ЊC for 50 sec, and extension at 72ЊC for 1 min, with a final extension step at 72ЊC for 5 min.
Amplified products were revealed by UV transillumination after electrophoresis on a 1.5% agarose gel. Amplicons generated by the COLSENS/COLREV primer set were also assayed by using a DNA enzyme immuno-assay (DEIA) kit (GEN-ETI-K DEIA; Sorin Biomedica, Antony, France). A specific biotinylated oligonucleotide, COLS2PROB, was used for specific detection of the PCR product (Table 1) .
A multiplex PCR amplification of the CTF virus segments 10, 11, and 12 was carried out. The reaction mixture (100 l) included 20 l of cDNA solution, 1.5 M of primer MULTISENS, 1 M of primer M6988GB, 0.1 M of primer S1A701, 0.1 M of primer S2259A, and 2.5 units of Taq polymerase (Boehringer Mannheim). The amplification program consisted of an initial cycle of progressive increase in temperature by steps of 5ЊC each lasting 30 sec from 40ЊC to 70ЊC (allowing the correct annealing of the MULTISENS primer) and an incubation at 72ЊC for 1 min (allowing the elongation of the cDNA along the nonhybridized part of the MULTISENS primer). This was followed by a denaturation cycle at 90ЊC for 10 min and 35 cycles of denaturation at 94ЊC for 50 sec, annealing at 60ЊC for 50 sec, and extension at 72ЊC for 1 min, with a final extension step at 72ЊC for 5 min. All reactions were carried out using a Hybaid (Ashford, Middlesex, United Kingdom) OmniGene thermal cycler.
Enzyme-linked immunosorbent assay for anti-CTF virus antibodies. The ELISA for detection of IgG antibodies was carried out as previously described, 15 with the only difference that the virus was propagated in suspensions of BHK-21 cells, which yield higher titer of antigen, rather than in Vero cells. Detection of IgM antibodies was done using a modification of the test of Calisher and others: 15 biotinconjugated anti-human IgMs (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) were fixed in the bottom of 96-well plaques previously coated with streptavidin (Sorin Biomedica). The remaining steps of the test were carried out as previously described. Ten paired sera obtained from the set of Calisher and others 15 (recovered from American individuals infected by the CTF virus with the following numbers: 2, 10, 18, 21, 22, 23, 26, 30, 31 , and 32) were tested. The acute-stage sera were designated by the letter (a) and were collected between days 0 and 4 after the clinical onset of the disease, and the convalescent sera were designated by the letter (c) and were collected between days 13 and 49 after the clinical onset of the disease. 15 Western blot analysis. Suspensions of BHK-21 cells infected (as well as noninfected) with CTF virus were centrifuged at 800 ϫ g at 4ЊC. The pelleted cells were dissolved by heating at 96ЊC for 5 min in 160 mM Tris-HCl, 4 mM EDTA, 3.6% sodium dodecyl sulfate (SDS), 60 mM DTT, 0.2% ␤-mercaptoethanol, 0.8% methionine, 800 mM sucrose. The equivalent of 10 7 cells was loaded per minigel (5 ϫ 10 5 cells per strip). The electrophoresis was performed for 1 hr at room temperature according to Laemmli 24 in a MiniproteanII apparatus (Bio-Rad Laboratories, Hercules, CA). Sucrose at a final concentration of 10% was incorporated in both the stacking and migration gels.
Electroblotting to a 0.45-m nitrocellulose membrane (Transblot-medium; Bio-Rad Laboratories) was carried out FIGURE 1. Amplification products of Colorado tick fever (CTF), S6-14-03, Eyach, and Ar/T578 viruses. Lanes M, molecular size markers indicated in basepairs (values on the left); lane 1, amplicons of the multiplex polymerase chain reaction (PCR) from segments M6, S1, and S2 of CTF virus (primers: MULTISENS, M6988GB, S1A701, and S2259A); lanes 2, 3, and 4, amplicons of PCRs from the S2 segment generated by the S2259S/S2259A, S2259S/COL-REV (all viruses), and COLSENS/COLREV (CTF and S6-14-03 viruses) sets of primers, respectively; lanes 5, 6, and 7, amplicons of PCRs from the segment S1 of CTF virus (primers S1S302/ S1A302, S1S302/S1A701, and S1S302/S1A902, respectively); lanes 8 and 9, amplicons of the PCRs from segment M6 of CTF virus primers M6TGAS/M6TGAA and M6988GA/M6988GB, respectively); lane 10 shows the amplicons of the PCR from segment M5 (primers M5720PS/M5720PA). for 90 min at 4ЊC. The transfer buffer contained 20 mM Tris, 0.05% SDS, 150 mM glycine, and 20 % isopropanol (v/v). The membranes were cut into strips for testing individual sera and treated as described by Sambrook and others. 25 Antibodies dilutions were 1:1,000 for anti-CTF virus mouse immune ascitic fluid (MIAF), 1:20 for the paired sera (40 l of each serum) mentioned in under the ELISA section and for a control serum from a noninfected individual; and 1: 250 for horseradish peroxidase-conjugated goat antibodies (anti-IgM plus IgG) (Sanofi Diagnostics Pasteur, Aulnay sous Bois, France). Peroxidase activity was detected using 4-chloro-1-naphthol substrate (Sigma, St. Louis, MO) according to the manufacturer's instructions. The color development was stopped by rinsing with distilled water.
RESULTS

Amplification of genomic segments by the RT-PCR
and sensitivity of detection of viral RNA. The PCR amplification using segment specific primer sets M5720PS/ M5720PA, M6988GA/M6988GB, M6TGAS/M6TGAA, S1S302/S1A302, S1S302/S1A701, S1S302/S1A902, S2259S/S2259A, S2259S/COLREV, and COLSENS/COL-REV yielded products having the expected lengths. The results are shown in Figure 1 . Table 2 summarizes the lengths of the amplification products obtained using these sets of primers.
The multiplex PCR amplification generated three products of 999, 678 and 492 basepairs (bp), respectively, corresponding to segments M6, S1, and S2 of CTF virus. The results are shown in Figure 1 .
The RT-PCR methodology enabled the detection of 10-100 plaque-forming units (pfu) of CTF virus (as determined by plaque assay titrations) in all cases when the amplification products were stained with ethidium bromide. As little as 0.01 pfu could be detected using the DEIA methodology. Viral RNA could be detected in infected mouse blood on the third day post-infection, and a similar result was obtained from blood recovered on the fifth day.
Using all sets of primers, the amplification products obtained from the CTF and the S6-14-03 viruses had the same size. The RNAs from the Eyach and the Ar/T578 viruses could be amplified with the S2259S/S2259A and the S2259S/COLREV sets of primers. The size of these amplification products was similar to that of the corresponding CTF virus amplicons (Table 2) ; the COLSENS/COLREV set of primers did not amplify these RNAs (Table 2) .
Enzyme-linked immunosorbent assay for anti-CTF virus antibodies. Our results for detection of IgG antibodies in the tested sera were in agreement with those obtained by Calisher and others 15 except for sera 10c and 26c, which we found to be positive. All convalescent sera tested for anti-CTF virus IgM antibodies were found to be positive (Table  3) .
Western blot. The Western blot analysis performed with the MIAF revealed 13 protein bands from 25.5 to 95 kD. The noninfected cells showed no cross-reactivity (Figure 2 ). 
* MIAF ϭ mouse immune ascitic fluid; CS ϭ control serum from a noninfected individual; a ϭ acute serum; c ϭ convalescent serum; ϩ ϭ reactivity to the related protein; Ϫ ϭ absence of reactivity.
When human paired sera were tested, reactivity was detected in all cases. The human negative control serum gave a completely negative result. The results are shown in Table 4 . A protein species having a molecular weight of approximately 38 kD was detected in all paired sera, as well as with the MIAF. The intensity of this signal was lighter in the acutephase sera. The results of the Western blot are compared with those of the ELISA in Table 3 .
DISCUSSION
Colorado tick fever is a tick-born viral disease. Until the identification of the genomic sequences of CTF virus, the diagnosis of viral infection was made by virus isolation and characterization on one hand, and by ELISA on the other. 15 Recently, we sequenced the M6, S1, and S2 genomic segments 19 of CTF virus (GenBank accession numbers AF000720, U72694, and U53227, respectively), as well as a part of the M5 genomic segment (GenBank accession number AF007172) of the Florio strain of CTF virus. This led to the development of molecular diagnostic procedures based on the S2 genomic sequence. 26 Using the protocol of Calisher and others 15 for the sera that we tested, our results for the detection of IgG antibodies by ELISA were comparable with those obtained by these investigators, with the exception of sera 10c and 26c, which we found to be positive. This is probably due to the higher antigen titer of the lysate prepared from suspensions of BHK-21 cells compared with the lysate from Vero cell monolayers. Moreover, the use of biotinylated anti-human IgM antibodies for the detection of specific IgM antibodies, together with that of the BHK-21 lysate, enabled the detection of anti-CTF virus IgMs in two sera that were reported to be negative by Calisher and others. 15 One serum (10c) was found to be unambiguously positive and the other (18c) had a reproducible threshold value. The enzyme immunoassay protocols that we used detected specific antibodies in sera that were previously found to be negative, but the small number of samples tested does not indicate a significant improvement of the sensitivity.
The Western blot that we used with the anti-CTF virus MIAF revealed 13 immunogenic protein species ranging from 25.5 to 95 kD. When this test was used for the analysis of paired human sera, it enabled the detection of antibodies to different CTF virus proteins, even in acute stage sera that were found to be negative by ELISA. All 13 proteins revealed by the anti-CTF virus MIAF could be detected by antibodies contained in the tested human sera. Serum 32c showed reactivity to 12 of the 13 immunogenic proteins; the 63-kD protein was detected by antibodies contained in seven other human sera. The Western blot pattern shown in Figure  2 that was obtained with the MIAF is therefore representative of the complete reactivity that could be detected by different human sera.
Interestingly, antibodies to a 38-kD CTF virus protein were detected in all paired sera. The intensity of this band was lighter in the acute-phase than in convalescent-phase sera. The presence of antibodies to this protein may be an early marker of the infection by CTF virus.
Calisher and others reported the presence of neutralizing antibodies in some sera that we tested and that they found to be negative by IgG-ELISA (e.g., 10c, 18c, and 26c). 15 The only convalescent serum that we found to be negative with the IgG-ELISA (serum 18c) was found to be positive by Western blot analysis.
Despite efforts to improve its sensitivity, the modified IgM antibody detection test did not detect IgM in acute stage sera. The identification of some immunoreactive proteins that are revealed by Western blot, namely the 38-kD and the 95-kD proteins, would result in a diagnostic procedure of higher sensitivity. Accordingly, the lack of sensitivity of the ELISA does not permit the use of this test alone as a diagnostic procedure for serologic screening, especially in the early stages of the viral infection. Based on our results, the only serologic test that could detect such a response is the Western blot. For these reasons, a specific and sensitive molecular detection test that allows a direct diagnostic evaluation of the infection through the amplification of different genomic regions of the viral RNA was developed.
Different sets of primers were designed from the sequences of CTF virus and used for the PCR amplification of the viral genome. Genomic segment-specific sets of primers were used and generated the expected amplification products. Interestingly, the primer sets S2259S/S2259A and S2259S/COLREV were found to amplify the CTF virusrelated viruses, i.e., the Ar/T578, Eyach and the S6-14-03 viruses. However, only the S6-14-03 and the CTF viruses were amplified by the COLSENS/COLREV primer set. Such a difference in the specificity of the used primers could allow a differential diagnosis of the European and the American strains of Coltiviruses. The Ar/T578 and Eyach viruses were serologically investigated by Chastel and others 11 and Karabatsos and others 16 , respectively, and the investigators concluded that these viruses were antigenically distinct from CTF virus but related to each other. The results of immunofluorescence studies we conducted on C6/ 36 cells infected with the Ar/T578 virus using anti-CTF virus immune ascitic fluid showed an appreciable crossreactivity with the CTF virus. This finding and the amplification profile using primer sets developed from genomic sequences of CTF virus suggest that all of these viruses exhibit a certain degree of homology, at least at the level of their genomic segment no. 12.
Johnson and others recently described the use of PCR primers located in the S2 region for the detection of CTF virus. 26 However, the set of primers used by these investigators for the primary PCR permitted the amplification of CTF virus genome, but also that of other unrelated genomes, including bacterial and rodent nucleic acid sequences.
Our approach, based on the design of multiple PCR targets, allowed the simultaneous amplification of three genomic segments of CTF virus, namely M6, S1, and S2. The design of a multiplex primer (primer MULTISENS) to serve as a sense primer common to the three segments is based on the conserved 5Ј terminal nucleotide sequences of the CTF virus (SACATTTTGTSTCW). This protocol of multiplex amplification was found to be very specific because it generated the three expected products with lengths of 999, 678, and 492 bp corresponding to segments M6, S1, and S2, respectively, without any parasitic DNA band. The fact that 1) three different primers located in three different genomic regions were used and 2) the sequences of these primers do not exhibit significant homologies with any of the reported non-CTF reovirus sequences (obtained from genome databases) ensures the specificity of detection by the PCR.
Experimental infections with CTF virus have been previously reported in mammals, 27 and virus has been isolated from a number of animals and humans. 3, 9, 16, 17, 28 The animal model (adult mice) that we have used supports CTF virus replication, as well as that of the related viruses (suckling mice). The viral RNA could be detected in the infected mouse blood as early as the third day postinfection. The RNA extracted from infected mouse blood gave the same amplification profile as that obtained from purified virus. The RNA from noninfected mouse blood gave negative results. The different sets of primers used in the RT-PCR amplification proved to be sensitive in detecting the viral RNA. When agarose gel electrophoresis and staining with ethidium bromide are used, 10-100 pfu of CTF virus could be detected. However the DNA enzyme immunoassay was more sensitive, detecting as little as 0.01 pfu in red blood cells. Based on these findings the RT-PCR can be recommended for use in the laboratory diagnosis of CTF virus infection.
Finally, proper use of the different serologic and molecular techniques we have developed should permit the biological diagnosis of the CTF virus infections at the different stages of its pathology. The identification of genomic segments coding for the early immunogenic proteins, namely the 38-kD and 95-kD viral proteins, could result in earlier serologic diagnosis of infection by ELISA with the recombinant protein technology or synthetic peptides. In the absence of such a test, the serologic response during the acute stage of infection should be monitored by Western blot analysis. Interestingly, a specific peptide encoded by the S2 segment (QSVYFKLYEFYKNNETARNTSV) was found to be immunoreactive and permitted the detection of anti-CTF virus IgM antibodies in acute stage sera of Calisher and others 15 when used with a slot blot methodology. However, the specificity and sensitivity of the elaborated PCR procedure render it the test of first choice for detecting the presence of the CTF virus in suspected cases of acute infection. The proposed RT-PCR detection systems should also initiate diagnostic and epidemiologic studies on Coltiviruses, especially on the European continent.
